News

Sept. 21, 2021

Antapodia Therapeutics, Inc., a specialty biopharmaceutical company with a goal of creating first-in-class and breakthrough therapies for invasive and metastatic cancers, debuts at BiopharmAmerica to present the company's lead programs and impressive POC animal data.

Logo_vertical_light.png

Designed by Justin V. Tsai in 2021

Copyright © Antapodia Therapeutics, Inc., WA, USA. All Rights Reserved.

Search